Sanket Koul

Union Health Ministry moves to remove repeated HIV, Hepatitis tests on pooled plasma to align with global norms and ease compliance while maintaining patient safety

The Centre will conduct a nationwide assessment of district hospitals to identify gaps in emergency and trauma care infrastructure and strengthen facilities in line with IPHS norms

Addressing the concluding session of the webinar, Dr VK Paul, member (health) at government think tank NITI Aayog said that the strategic way forward includes strengthening existing institutions

Bhagwati Products has leased 430,000 sq ft in Oppo's Noida plant to expand smartphone output, marking another major industrial space deal amid strong demand in NCR's manufacturing hubs

Experts add that while the introduction of branded generics will trigger an acceleration in volumes for GLP-1 agonists, the value growth may moderate due to price erosion

The Indian pharmaceutical market posted 11% growth in February 2026, driven by strong therapy performance, while Mounjaro remained India's highest-selling drug by value for a fifth month

Metlife's global capacity centre has leased 75,000 sq ft at Embassy's Oxygen Business Park in Noida, adding to strong Grade-A office demand amid rising GCC activity and tech sector expansion

Embassy REIT has raised ₹1,400 crore through a fully subscribed 10-year NCD issue, expanding its institutional investor base as the trust continues to secure long-duration capital

Joint degrees and credit-sharing emerge as response to visa curbs and a 45% drop

At least 2-3 more foreign universities to open campuses in India this year

Indian drugmakers are reviewing shipment schedules and inventories for West Asia as escalating tensions threaten sea and air routes, raising freight costs and risking supply delays

Gaurs Group will invest Rs 250 crore to build a precast and modular construction facility in Noida after signing an MoU with Elematic India, aiming to boost efficiency and project timelines

TARC will prioritise Delhi and Gurugram in FY27 with phased launches across existing luxury projects, backed by strong demand momentum and projected cash-flow visibility over four years

Abbott will commercialise Extensior, a second semaglutide brand of Ozempic in India, as part of Novo Nordisk's strategy to expand access amid rising demand and looming patent expiry

NBCC has signed two MoUs with DDA for redeveloping staff colonies at Old Rajinder Nagar and Safdarjung Development Area, securing Rs 775 crore in projects under a self-sustainable model

CDSCO will permit drugmakers to begin testing samples as soon as applications are filed, shifting detailed scrutiny to later stages to shorten approval timelines and ease compliance

A Knight Frank-Deloitte report says foreign universities establishing campuses in India could help retain $113 billion in foreign currency by 2040, easing large outflows for overseas education

Eris Lifesciences partners with Natco Pharma to commercialise semaglutide in India in 2026, as rising demand and impending patent expiry fuel intense competition in metabolic and weight-loss therapies

India will launch a nationwide, free and voluntary HPV vaccination campaign for 14-year-old girls, using Gardasil under strict quality norms, as part of efforts to eliminate cervical cancer

Firms upbeat as Delhi-Meerut RRTS now fully operational